信息搜索
信息关键字:证
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265]

·国泰君安证券:新标准将带来商用密码行业需求爆发式增长,市场空间接近200亿元2023-11-2 7:10:43
·美联储主席鲍威尔:GDP高于潜在水平的证据可以证明加息是合理的2023-11-2 3:21:59
·海川智能:取得一项专利证书2023-11-1 23:22:41
·证监会:要健全多层次市场体系,支持上海、深圳证券交易所建设世界一流交易所2023-11-1 21:28:19
·证监会:要对财务造假、欺诈发行、操纵市场等违法行为重拳打击2023-11-1 21:24:09
·人福医药:控股子公司收到利伐沙班片《药品注册证书》2023-11-1 19:17:26
·西部证券:数据资产入表将带来大量数据确权需求2023-11-1 19:16:47
·人福医药:获得利伐沙班片注册证书 盐酸纳布啡注射液获得补充申请批准通知书2023-11-1 17:13:22
·国药现代:盐酸莫西沙星滴眼液获得药品注册证书2023-11-1 15:52:19
·如何更好发挥资本市场枢纽功能?证监会解读2023-11-1 15:28:11
·证监会:规范发行和交易行为,及时评估优化股份减持、融资融券、再融资等机制安排2023-11-1 15:18:49
·商务部副部长郭婷婷:将支持境外金融机构在新疆自贸试验区设立银行、保险、证券等金融机构2023-11-1 13:31:00
·证券行业周报:政策利好正在兑现,市场有望延续反弹2023-11-1 10:19:26
·广发证券:A股中报盈利底确认 可选消费及TMT利润率持续改善2023-11-1 8:11:22
·华泰证券:假期移位拉低制造业PMI2023-11-1 7:46:00
·股票行情快报:长城证券(002939)10月31日主力资金净卖出843.17万元2023-11-1 1:27:36
·中泰证券首席经济学家李迅雷:中央金融工作会议对发展资本市场提出了更高要求2023-10-31 22:21:48
·南纺股份:证券简称拟变更为“南京商旅”2023-10-31 20:27:30
·南纺股份:拟将证券简称变更为“南京商旅”2023-10-31 18:55:19
·诚意药业:硫唑嘌呤片获得药品注册证书2023-10-31 17:16:51

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265]